NSECertificate under SEBI (Depositories and Participants) Regulations, 20189 Jul 2026 · 9 Jul 2026, 03:56 pm
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Bafna Pharmaceuticals Limited · BAFNAPH
✦ AI Summary
Bafna Pharmaceuticals Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026, confirming the dematerialization of securities and listing on stock exchanges.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Bafna Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026.
Attachments (1)
📄pdf
Download →
BAFNAPH_09072026155557_REGULATION_74_5_.pdf
View document text
BAFNA PHARMACEUTICALS LIMITED
REGD. OFFICE: “BAFNA TOWERS”, NO.299, THAMBU CHETTY STREET, CHENNAI – 600001, TAMIL NADU, INDIA
PHONE: 044-25267517/25270992/42677555, FAX: 91-44-25231264, Email: info@bafnapharma.com, Website: www.bafnapharma.com
CIN: L24294TN1995PLCO30698
Date: July 09, 2026
BSE Limited, National Stock Exchange of India Limited,
Phiroze Jeejeebhoy Towers, Exchange Plaza,
Dalal Street, Bandra Kurla Complex,
Mumbai - 400001. Bandra East, Mumbai – 400051.
Scrip Code: 532989 Scrip Code: BAFNAPH
Dear Sir/Madam,
Sub: Certificate under Regulation 74(5) of the SEBI (Depositories And Participants)
Regulations, 2018 for the Quarter ended June 30, 2026
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018,
we enclose herewith a copy of the Certificate received from M/s. Cameo Corporate
Services Limited, the Registrar and Share Transfer Agent (RTA) of the Company, for the
Quarter ended June 30, 2026.
We request you to take the document on record.
Thanking You.
For BAFNA PHARMACEUTICALS LIMITED
Mohanachandran A
Company Secretary & Compliance Officer
Factory: No.147, Madhavaram Redhills High Road, Grantlyon Village, Vadakarai Post, Chennai-600 052, TN, India Phone: 9445149001 Email: factory1@bafnapharma.com
CAMEO CORPORATE SERVICES LIMITED
Ref: CAM/BPR/74(5)/2026
6th July, 2026
THE COMPANY SECRETARY
M/S. BAFNA PHARMACEUTICALS LIMITED
BAFNA TOWERS
NO 299 THAMBU CHETTY STREET
CHENNAI
TAMILNADU
600001
Dear Sir,
Subject: Certificate under of Regulation 74(5) of Securities and Exchange
Board of India (Depositories and Participants) Regulations, 2018
for the quarter ended 30.06.2026.
------
With reference to the above captioned subject, we hereby confirm that the
securities received from the depository participants for
dematerialisation during the quarter ended 30th June 2026, were confirmed
(accepted/rejected) to the depositories by us and that securities
comprised in the said certificates have been listed on the stock
exchanges where the earlier issued securities are listed.
We hereby also confirm that the security certificates received for
dematerialisation have been mutilated and cancelled after due
verification by the depository participant and the name of the
depositories have been substituted in register of members as the
registered owner within stipulated time limit under captioned
regulations.
Thanking you
Yours faithfully
For CAMEO CORPORATE SERVICES LIMITED
ASST. MANAGER (SHARES)
CIN No:U67120TN1998PLC041613
'Subramanian Building', No.1, Club House Road, Chennai-600 002.
Phone: (D) 044-40020710 / 044-2846 0390, Fax: 044-2846 0129
E-mail: cameo@cameoindia.com Website: www.cameoindia.com